Nexelis Revenue and Competitors

As the embodiment of our corporate vision, our name and its structural components are a constant affirmation of who we are, what we do and how we do it. Through these partnerships and our experienced scientists we have optimized study outcomes, decreased sponsors? timelines for FDA approval, and provided competitive product differentiation. From long experience, we believe that success in our field is best achieved by a fusion of scientific discipline, human agility and client partnership. Together, these guiding principles provide a solid working foundation, enabling our teams to excel with every mission, no matter how demanding, complex, or time sensitive. It can truly be said that Nexelis came into existence as a meeting of minds, giving us a clear perspective from each side of the CRO/client relationship. In Canada, we emerged from GSK as the NEOMED-LABS with extensive knowledge and a deep pharma mindset. In the United States, we grew from a University of Washington research unit to earn wide respect as Pacific Biomarkers. More recently, we were joined by PAIRimmune, a knowledgeable CRO with major pre-clinical expertise. Today, with unified management and an aligned direction, we bring to our clients over 10 years of bioanalysis, 15 years of vaccine and 25 years of biomarker experience.